Poster 170 : Apitegromab in spinal muscular atrophy: baseline characteristics of participants enrolled in the phase 3 SAPPHIRE study

Crawford T, Servais L, Krueger J, Kolbel H, Gomez Garcia M, Cances C, Kuntz N, Finkel R, Yao B, Zhao G, Marantz J, Darras B, Mercuri E

Neuromuscular disorders : NMD